Get started
Work

Outcomes and Risks of Autologous Hematopoietic Stem Cell Transplant for Hematological Malignancies in Patients with HIV Infection

Year: 2018
Type: article
Abstract: Background: Prevalence worldwide of HIV is currently around 37 million. Those infected are at increased risk of developing hematological malignancies (HM). Autologous hematopoietic stem cell transplant (autoHSCT) is a potentially curative therapy for HM. Many uncertainties exist for HSCT in HIV patients including conditioning regimens, the risk of infection and outcomes.
DOI: 10.1016/j.bbmt.2017.12.083
Authors: Shukaib Arslan, Jessica Lee, Sonia Shoukat, Nathan W. Cummins, Andrew D. Badley, Mark R. Litzow, Willis H. Navarro, Shahrukh K. Hashmi
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2787678390
FWCI:
Cites:
Cited by:
Related to: 10